| CH3CN | Acetonitrile |
| CPM | Count per minute |
| c(RGDfK | Cyclic arginine-glycine-aspartate-D-phenylalanine-lysine |
| CRT | Chemoradiotheranostic |
| 64Cu | Copper-64 |
| 64Cu(OAc)2 | 64Cu-Acetate |
| 64CuCl2 | 64Cu-Chloride |
| DCM | Dichlorometane |
| DIPEA | N,N-Diisopropylethylamine |
| DMEM | Dulbecco’s modified Eagle medium |
| DMF | N,N-Dimethylformamide |
| DNA | Deoxyribonucleic acid |
| EC50 | Effective concentration |
| EMEM | Eagle’s minimal essential medium |
| Equiv | Equivalent |
| ESI | Electrospray ionization |
| Fmoc | Fluorenylmethyloxycarbonyl |
| GBM | Glioblastoma multiforme |
| H2O | Water |
| HATU | Dimethylamino-N,N-dimethyl(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methaniminium hexafluorophosphate |
| HOBt | Hydroxybenzotriazole |
| HPLC | High performance liquid chromatography |
| HRMS | High-resolution mass spectrometry |
| IC50 | Inhibitory concentration |
| iTLC | Instant thin layer chromatography |
| ivDde | 1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl |
| MeOH | Methanol |
| MG | Malignant glioblastoma |
| MS | Mass spectrometry |
| 64Ni | Nickel-64 |
| NOTA | 2,2′,2″-(1,4,7-Triazacyclononane-1,4,7-triyl)triacetic acid |
| PET | Positron Emission Tomography |
| Pd(PPh3)4 | Tetrakis(triphenylphosphine)palladium(0) |
| PhSiH3, | Phenylsilane |
| PyBOP | Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate |
| RGD | Arginine-glycine-aspartate |
| Rt | Retention time |
| TACN | Triazacyclononane |
| TFA | Trifluoroacetic acid |
| TIPS | Triisopropylsilane |
| TMZ | Temozolomide |
| TP | Terpyridine platinum |
| μM | Micromolar |